Inhibitory effect of hexahydrocurcumin on human platelet aggregation.
The effects of hexahydrocurcumin on adenosine diphosphate (ADP)-induced human platelet aggregation were studied. Treatment of human platelet-rich plasma with hexahydrocurcumin resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans.
Department of Physical Therapy, Fooyin University, Kaohsiung, Taiwan.
Huei-Ping
HP
Dong
Rei-Cheng
RC
Yang
I-Chun
IC
Chunag
Li-Ju
LJ
Huang
Hsing-Tan
HT
Li
Hsin-Liang
HL
Chen
Chung-Yi
CY
Chen
D003474:Curcumin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D015394:Molecular Structure; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000737:chemistry / Q000494:pharmacology*
D010975:Platelet Aggregation Inhibitors; C569902:hexahydrocurcumin; D003474:Curcumin